Related Experiment Video
Updated: Dec 23, 2025
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.7K
An Electronic Medication Module to Improve Health Literacy in Patients With Type 2 Diabetes Mellitus: Pilot
Hanna Marita Seidling1,2, Cornelia Mahler3,4, Beate Strauß3
1Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
JMIR Formative Research
|April 29, 2020
Summary
An internet-based medication module did not improve health literacy in type 2 diabetes patients. Poor implementation and potential ceiling effects may have contributed to the null findings in this study.
Area of Science:
- Health literacy research
- Digital health interventions
- Primary care research
Background:
- Patient engagement is vital for managing chronic conditions like type 2 diabetes.
- Health literacy significantly impacts patient adherence to drug treatments.
- Interventions are needed to empower patients in their care management.
Purpose of the Study:
- To evaluate the impact of a patient-led electronic health record medication module on health literacy.
- To assess if digital tools can enhance patient understanding of medications.
Main Methods:
- A randomized controlled trial was conducted with community-dwelling patients with type 2 diabetes.
- The intervention group used an internet-based medication module; the control group received a brochure.
- Health literacy was measured using questionnaires at baseline and follow-up (4-8 weeks).
Main Results:
- No significant differences in health literacy were observed between the intervention and control groups.
- A high completion rate (92.2%) was noted, but per-protocol analysis included only 73 patients.
- Poor implementation and potential ceiling effects were identified as reasons for the null result.
Conclusions:
- The study did not demonstrate a significant improvement in health literacy using the medication module.
- Challenges in implementation and study duration may have influenced the outcomes.
- Piloting complex interventions with process evaluations is recommended.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
782
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
782
01:21Health Literacy
5.1K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.1K
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:26Atherosclerosis III: Management
263
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
473
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
473